Monopar Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Monopar Therapeutics has a total shareholder equity of $6.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $7.2M and $1.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.12m |
| Equity | US$6.09m |
| Total liabilities | US$1.09m |
| Total assets | US$7.18m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1IY0's short term assets ($7.2M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: 1IY0 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1IY0 is debt free.
Reducing Debt: 1IY0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1IY0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1IY0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.8% each year